Immunogenic Switch of RPE Cells.

Area of Science:

• Ophthalmology
• Immunology
• Cell Biology

Background:

• The retinal pigment epithelium (RPE) forms a critical barrier, maintaining retinal immune privilege through tight junctions and immune-suppressive factors.
• In retinal diseases like age-related macular degeneration (AMD), this barrier function is compromised, allowing immune cell infiltration.
• The RPE's response to inflammation can shift from immune-suppressive to immune-stimulating, exacerbating disease pathology.

Purpose of the Study:

• To investigate the role of the transcription factor FoxP3 in RPE cells during retinal inflammation and disease.
• To determine if FoxP3 expression in RPE cells correlates with AMD pathogenesis.
• To understand the immunogenic switch in RPE cells from anti-inflammatory to pro-inflammatory.

Main Methods:

• Analysis of RPE cells in mouse models relevant to age-related macular degeneration (AMD).
• Examination of RPE cells from human retinas of AMD patients and healthy donors.
• Assessment of FoxP3 expression and its correlation with inflammatory markers (e.g., IL1β, complement).

Main Results:

• Stressed RPE cells express the transcription factor FoxP3.
• FoxP3 activation in RPE cells leads to the secretion of pro-inflammatory factors.
• FoxP3 is present in RPE cells of AMD mouse models and human AMD retinas, but not in healthy controls.
• FoxP3 initially acts as a rescue factor but ultimately drives a pro-inflammatory phenotype in RPE.

Conclusions:

• FoxP3 expression in RPE cells is a key event in the immunogenic switch observed in AMD.
• The RPE's transition to a pro-inflammatory phenotype, mediated by FoxP3, contributes to AMD pathology.
• Targeting FoxP3 in RPE cells may offer a therapeutic strategy for AMD by restoring immune homeostasis.